Nanjing Julong Science&Technology Co.,LTD
SZSE:300644.SZ
17.92 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 1,828.938 | 1,707.541 | 1,659.361 | 1,138.671 | 953.249 | 1,018.193 | 1,023.75 | 903.332 | 820.404 | 915.446 |
Cost of Revenue
| 1,534.197 | 1,483.924 | 1,467.634 | 929.65 | 801.363 | 885.372 | 844.083 | 679.76 | 605.812 | 746.554 |
Gross Profit
| 294.741 | 223.617 | 191.726 | 209.021 | 151.886 | 132.821 | 179.666 | 223.572 | 214.592 | 168.892 |
Gross Profit Ratio
| 0.161 | 0.131 | 0.116 | 0.184 | 0.159 | 0.13 | 0.175 | 0.247 | 0.262 | 0.184 |
Reseach & Development Expenses
| 71.745 | 60.341 | 57.872 | 46.621 | 36.869 | 37.328 | 35.003 | 35.962 | 29.274 | 32.28 |
General & Administrative Expenses
| 25.139 | 20.398 | 20.197 | 20.36 | 11.139 | 9.134 | 8.041 | 11.087 | 6.583 | 69.805 |
Selling & Marketing Expenses
| 13.986 | 26.425 | 23.94 | 23.311 | 44.56 | 39.073 | 37.622 | 41.465 | 44.988 | 41.308 |
SG&A
| 39.125 | 46.823 | 44.137 | 43.67 | 55.699 | 48.207 | 45.663 | 52.552 | 51.57 | 111.114 |
Other Expenses
| 109.777 | 0.359 | 1.521 | -3.445 | 0.049 | 4.634 | 1.476 | 9.924 | 3.823 | 5.949 |
Operating Expenses
| 220.646 | 146.144 | 131.994 | 118.074 | 120.264 | 109.297 | 107.324 | 126.629 | 116.037 | 113.576 |
Operating Income
| 74.094 | 54.446 | 28.368 | 72.386 | 29.816 | 20.66 | 64.025 | 82.291 | 85.439 | 42.619 |
Operating Income Ratio
| 0.041 | 0.032 | 0.017 | 0.064 | 0.031 | 0.02 | 0.063 | 0.091 | 0.104 | 0.047 |
Total Other Income Expenses Net
| -0.032 | 0.038 | 1.533 | -3.445 | -0.57 | 4.634 | 1.476 | 3.894 | -4.977 | -2.37 |
Income Before Tax
| 74.063 | 54.1 | 29.901 | 68.942 | 29.865 | 25.294 | 65.502 | 92.215 | 89.262 | 48.568 |
Income Before Tax Ratio
| 0.04 | 0.032 | 0.018 | 0.061 | 0.031 | 0.025 | 0.064 | 0.102 | 0.109 | 0.053 |
Income Tax Expense
| 5.966 | 0.38 | -0.48 | 7.698 | 0.664 | 2.838 | 9.349 | 14.986 | 14.996 | 6.564 |
Net Income
| 72.548 | 55.404 | 31.784 | 61.169 | 29.273 | 23.026 | 56.433 | 78.66 | 75.123 | 42.056 |
Net Income Ratio
| 0.04 | 0.032 | 0.019 | 0.054 | 0.031 | 0.023 | 0.055 | 0.087 | 0.092 | 0.046 |
EPS
| 0.68 | 0.51 | 0.3 | 0.57 | 0.27 | 0.22 | 0.69 | 0.99 | 1.01 | 0.56 |
EPS Diluted
| 0.68 | 0.51 | 0.3 | 0.57 | 0.27 | 0.22 | 0.69 | 0.99 | 1.01 | 0.56 |
EBITDA
| 149.953 | 112.532 | 75.861 | 95.824 | 57.905 | 54.667 | 92.702 | 116.143 | 114.309 | 70.59 |
EBITDA Ratio
| 0.082 | 0.071 | 0.057 | 0.094 | 0.06 | 0.054 | 0.091 | 0.138 | 0.145 | 0.082 |